Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
2 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
65. 30
-0.03
-0.05%
$
14.49B Market Cap
38.79 P/E Ratio
0% Div Yield
2,281,400 Volume
3.91 Eps
$ 65.33
Previous Close
Day Range
64.56 65.52
Year Range
51.9 84.67
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 25 days

Summary

HOLX closed today lower at $65.3, a decrease of 0.05% from yesterday's close, completing a monthly increase of 0.68% or $0.44. Over the past 12 months, HOLX stock lost -9.82%.
HOLX is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.34%, based on the last three reports. The next scheduled earnings report is due on Jul 28, 2025.
Hologic Inc. has completed 3 stock splits, with the recent split occurring on Apr 03, 2008.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

HOLX Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025.

Businesswire | 12 hours ago
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern

Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern

HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.

Zacks | 18 hours ago
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing

Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.

Zacks | 6 days ago

Hologic Inc. Dividends

HOLX is not paying dividends to its shareholders.

Hologic Inc. Earnings

28 Jul 2025 (In 3 weeks) Date
1.05
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
1.02
Cons. EPS
1.03
EPS
7 Nov 2024 Date
1.02
Cons. EPS
-
EPS
4 Nov 2024 Date
1.01
Cons. EPS
1.01
EPS
HOLX is not paying dividends to its shareholders.
28 Jul 2025 (In 3 weeks) Date
1.05
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
1.02
Cons. EPS
1.03
EPS
7 Nov 2024 Date
1.02
Cons. EPS
-
EPS
4 Nov 2024 Date
1.01
Cons. EPS
1.01
EPS

Hologic Inc. (HOLX) FAQ

What is the stock price today?

The current price is $65.30.

On which exchange is it traded?

Hologic Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is HOLX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 14.49B.

What is the earnings per share?

The EPS is 1.05.

When is the next earnings date?

The next earnings report will release on Jul 28, 2025.

Has Hologic Inc. ever had a stock split?

Hologic Inc. had 3 splits and the recent split was on Apr 03, 2008.

Hologic Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Stephen P. MacMillan CEO
NASDAQ (NGS) Exchange
436440101 Cusip
US Country
7,063 Employees
- Last Dividend
3 Apr 2008 Last Split
21 Jun 1990 IPO Date

Overview

Hologic, Inc. is a pioneering company focused on improving women’s health through early detection and treatment, leveraging advanced diagnostics, medical imaging systems, and surgical products. Founded in 1985 with its headquarters in Marlborough, Massachusetts, Hologic operates across four distinct segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its commitment to innovation and improving patient outcomes positions Hologic as a leader in the healthcare industry, ensuring it meets the diverse needs of healthcare providers and patients alike.

Products and Services

  • Aptima Molecular Diagnostic Assays: These assays are designed to detect infectious microorganisms, playing a crucial role in the diagnosis and management of infectious diseases.
  • Aptima Viral Load Assays: Specifies viral load measurements for Hepatitis B, Hepatitis C, HIV, and human cytomegalovirus, critical for monitoring and managing these infections.
  • Aptima Bacterial Vaginosis and Candida Vaginitis Assays: Offer diagnosis solutions for vaginitis, improving patient care through accurate detection.
  • Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 Assays: Enable the detection of SARS-CoV-2, the virus responsible for COVID-19, showcasing Hologic's capacity to respond to emergent health threats.
  • ThinPrep System: Provides cytology applications, enhancing the accuracy of Pap tests for detecting cervical cancer at early stages.
  • Rapid Fetal Fibronectin Test: Aids in assessing the risk of pre-term birth, offering critical information to healthcare providers for managing pregnancies.
  • 3D Digital Mammography Systems: Revolutionizes breast cancer detection with advanced imaging technology, improving the early diagnosis of breast cancer.
  • MyoSure Hysteroscopic Tissue Removal System: Allows for the minimally invasive removal of fibroids and polyps in the uterus, contributing to enhanced patient comfort and recovery.
  • NovaSure Endometrial Ablation System: Provides treatment for abnormal uterine bleeding, offering an effective alternative to more invasive surgical procedures.
  • Fluent Fluid Management System: Delivers liquid distention during hysteroscopic procedures, ensuring operational efficiency and safety.
  • Acessa ProVu System: A minimally invasive solution for treating fibroids, demonstrating Hologic’s commitment to innovative treatment options.
  • CoolSeal Portfolio: Features bipolar vessel sealing devices designed for surgical efficiency and patient safety during procedures.
  • Horizon DXA: This dual-energy X-ray absorptiometry system is used for assessing bone density, aiding in the detection and treatment of osteoporosis.
  • Fluoroscan Insight FD Mini C-arm: A compact imaging solution for orthopedic surgical procedures, enhancing the visualization needed for minimally invasive interventions.

Contact Information

Address: 250 Campus Drive
Phone: 508 263 2900